Preparing a Drug Registration for the US and the EU: Parallel or sequential applications? – Part 1
Published on: Feb 2, 2015
An overview of the main challenges faced by marketing authorisation applicants for the conversion of a dossier from one region to another, and deciding between a sequential and a parallel preparation.
Nathalie Boeglin, Alice Rolland, Frederic Pailloux and David Uguen.
February 2015 – Regulatory Rapporteur
Download the full resource now
Fill in the form to download the content